DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0678222 | Breast Carcinoma | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0017919 | Glycogen Storage Disease | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0205734 | Diabetes, Autoimmune | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0020459 | Hyperinsulinism | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0021670 | insulinoma | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0085207 | Gestational Diabetes | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0271650 | Impaired glucose tolerance | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0024623 | Malignant neoplasm of stomach | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0027651 | Neoplasms | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0010674 | Cystic Fibrosis | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0017205 | Gaucher Disease | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0699791 | Stomach Carcinoma | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C1961835 | Gaucher Disease, Type 1 | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0011854 | Diabetes Mellitus, Insulin-Dependent | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0740858 | Substance abuse problem | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0264408 | Childhood asthma | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C2239176 | Liver carcinoma | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C1096184 | West Nile viral infection | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C3495801 | Granulomatosis with polyangiitis | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0013170 | Drug habituation | GBA3 | 57733 | glucosylceramidase beta 3 (gene/pseudogene) | Q9H227 |
C0037773 | Spastic Paraplegia, Hereditary | GBA2 | 57704 | glucosylceramidase beta 2 | Q9HCG7 |
C0036439 | Scoliosis, unspecified | GBA2 | 57704 | glucosylceramidase beta 2 | Q9HCG7 |
C2828721 | SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE | GBA2 | 57704 | glucosylceramidase beta 2 | Q9HCG7 |
C0018784 | Sensorineural Hearing Loss (disorder) | GBA2 | 57704 | glucosylceramidase beta 2 | Q9HCG7 |
C0027651 | Neoplasms | GBA2 | 57704 | glucosylceramidase beta 2 | Q9HCG7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024